# Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

> **NCT00438113** · PHASE4 · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 184 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Aggressive Blood Pressure control

## Key facts

- **NCT ID:** NCT00438113
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438113, "Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00438113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*